Bionoxx Inc.
Bionoxx Inc.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 1 Study of OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients (South Korea) | Treatment-Refractory Solid Tumors | Recruiting | Phase 1 | 2026-08-26 | NCT07190833 | |
| A Phase 1 Study of OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients | Treatment-Refractory Solid Tumors | Not yet recruiting | Phase 1 | 2026-08-26 | NCT07170592 |